Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Amdocs stock

DOX
GB0022569080
915119

Price

88.16
Today +/-
+0.12
Today %
+0.15 %
P

Amdocs stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Amdocs stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Amdocs stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Amdocs stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Amdocs's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Amdocs Stock Price History

DateAmdocs Price
10/3/202488.16 undefined
10/2/202488.03 undefined
10/1/202487.38 undefined
9/30/202487.48 undefined
9/27/202487.83 undefined
9/26/202487.34 undefined
9/25/202485.90 undefined
9/24/202486.71 undefined
9/23/202486.47 undefined
9/20/202486.21 undefined
9/19/202487.29 undefined
9/18/202486.26 undefined
9/17/202486.41 undefined
9/16/202486.94 undefined
9/13/202486.49 undefined
9/12/202485.05 undefined
9/11/202485.05 undefined
9/10/202485.84 undefined
9/9/202485.40 undefined
9/6/202484.91 undefined
9/5/202485.67 undefined

Amdocs Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Amdocs, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Amdocs from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Amdocs’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Amdocs. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Amdocs’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Amdocs’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Amdocs’s growth potential.

Amdocs Revenue, EBIT and net profit per share

DateAmdocs RevenueAmdocs EBITAmdocs Net Income
2026e5.5 B undefined1.05 B undefined877.45 M undefined
2025e5.25 B undefined982.65 M undefined811.76 M undefined
2024e5.06 B undefined899.63 M undefined742.93 M undefined
20234.89 B undefined724.89 M undefined531.54 M undefined
20224.58 B undefined664.8 M undefined541.62 M undefined
20214.29 B undefined598.69 M undefined681.32 M undefined
20204.17 B undefined594.8 M undefined494.2 M undefined
20194.09 B undefined570.4 M undefined476.2 M undefined
20183.97 B undefined513.4 M undefined351.7 M undefined
20173.87 B undefined517.3 M undefined433.3 M undefined
20163.72 B undefined483.1 M undefined405.7 M undefined
20153.64 B undefined528.9 M undefined441.6 M undefined
20143.56 B undefined495.6 M undefined422.1 M undefined
20133.35 B undefined481.6 M undefined412.4 M undefined
20123.25 B undefined442.5 M undefined391.4 M undefined
20113.18 B undefined404.4 M undefined346.7 M undefined
20102.98 B undefined410.4 M undefined343.9 M undefined
20092.86 B undefined388.1 M undefined326.2 M undefined
20083.16 B undefined419.5 M undefined378.9 M undefined
20072.84 B undefined364.2 M undefined364.9 M undefined
20062.48 B undefined357.8 M undefined318.6 M undefined
20052.04 B undefined351.1 M undefined288.6 M undefined
20041.77 B undefined296.2 M undefined234.9 M undefined

Amdocs Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0.090.120.170.210.290.40.631.121.531.611.481.772.042.482.843.162.862.983.183.253.353.563.643.723.873.974.094.174.294.584.895.065.255.5
-28.7238.0226.3537.4438.9755.3378.5937.125.22-8.0619.5514.9521.6914.3511.50-9.494.266.472.173.056.522.252.064.012.772.822.032.856.726.803.463.844.72
46.8144.6341.9236.9738.6239.9542.0142.2244.3642.1638.4436.6636.4636.1336.6435.9035.9236.1334.8835.7735.2235.2535.5235.2335.1434.7035.0733.8934.4435.3835.34---
0.040.050.070.080.110.160.260.470.680.680.570.650.740.91.041.141.031.081.111.161.181.261.291.311.361.381.431.411.481.621.73000
0.030.020.020.040.050.080.150.150.160.10.220.30.350.360.360.420.390.410.40.440.480.50.530.480.520.510.570.590.60.660.720.90.981.05
26.6018.188.9816.5918.6220.8423.4813.3310.376.2015.1016.6917.2214.4012.8313.2513.5613.7412.7213.6214.3813.8914.4912.9913.3712.9113.9514.2513.9514.5114.8117.7818.7019.03
1916112453098666-5168234288318364378326343346391412422441405433351476494681541531742811877
--15.79-31.25118.18-79.17500.00226.67-93.881,000.00-107.58-3,460.0039.2923.0810.4214.473.85-13.765.210.8713.015.372.434.50-8.166.91-18.9435.613.7837.85-20.56-1.8539.749.308.14
----------------------------------
----------------------------------
92.292.2100.3110.5110.9159.4200.3216.9226.8220.4219.9220.3217.2218.5223.3220.3208.4204.1186.6169.4163.1161.4155.2149.9146.3142.6137.2133.2127.97121.89118.49000
----------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Amdocs Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Amdocs is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                       
0.020.050.030.090.41.111.051.291.191.150.981.181.241.171.431.171.121.331.421.351.10.980.520.470.980.970.820.74
44.66490159.3263.1384.9312.7198.3254.8304.2425.8473.8573.8455580565.9687.2678.2715.8714.8818.5865.1971.5987.9861866.82946.78944.48
00000000000000000000000058.453.9356.9644.53
0000000000000000000000000000
12.818.726.546.369.576.9120.4146.8142.5178233.5216.3187.4244.5238.5240235.7277.5283.6309.3186.1203.8230216.1171.3181.16181.43180.09
0.070.140.140.290.731.571.481.641.591.631.641.872.011.872.251.982.042.282.422.382.12.051.721.682.072.0721.91
1928.346.484128.1173.7160.9203.5181.1181.8220.3283.8317.1279.7258.3258.4277.9275.5289309.3331.7355.7496.6525.3903.4931.93971.17951.86
0000000000000000000000000000
00000000000047.138.64332.717.20000000053.9256.960
02623.422.800058.847.5159.6347.7303.5270.6227.3218.8193.4141.3156.70252.5281.5177.3265.2205.2296.3259.03178.31181.54
00001.010.790.750.80.810.971.461.491.531.541.641.741.741.822.112.052.212.222.442.462.582.622.662.75
12.129.928.332.46190.7147.8182.1240.4263.7294.5399.4412.4370.8411.3433426393.1365.9335.6406.1476.7420.4423.9488.6630.67574.94631.58
0.030.080.10.141.21.051.061.241.281.572.322.482.572.462.572.662.62.642.762.953.233.233.633.624.274.54.444.51
0.10.220.240.431.942.622.542.882.863.23.964.354.584.334.824.644.654.935.195.325.335.285.355.296.346.576.456.43
                                                       
1.723.13.23.53.63.63.63.63.63.83.93.93.9444.14.204.34.44.44.44.54.54.524.554.57
0.010.110.450.491.781.811.821.821.841.872.042.172.262.332.42.52.632.8803.183.323.463.593.673.813.954.114.24
-0-0.01-0.46-0.36-0.36-0.29-0.3-0.130.110.40.711.081.461.792.132.482.853.1803.854.144.464.675.015.345.856.216.55
00-0.01-0.010-0.01-00-0-0.0100-0.010.010-0.02-0.0303.4-0.020.010.02-0.03-00.010.01-0.05-0.04
000000000000000000000-0.4-1.600-1.27-22.8-16.2
0.020.09-0.020.121.431.511.531.71.952.262.763.253.714.134.544.965.456.063.47.027.487.948.238.689.179.8210.2510.75
31.730.547.668.6128.2166.5192.1224.3242.1313.9418.7415382.186.2168.3127167.6132.7785.5112136.7126.4194.7176.5110.1121.2134.4293.34
023.129.940.170.210486.9106.9124.3148.4178.4177.9218.2329.2453.2467.6523.2536.70741.8851.6634.8728.4705.8683.8736.73649.96693.64
14.937.654.1138.1188.7231.1252.9307.6386.8388.1432.6380.5228.1195.5202.6166.6174.7204.8205.2289.7177.7411.7371.9325.6322.2445.94468.32366.39
03.30000000000000000000000100000
17.5494.58.128.710.410.3429.821.38.522.11.702002502002002102202000000000
0.060.10.230.250.420.510.541.070.770.861.030.980.830.611.021.011.071.071.21.361.371.171.31.211.221.31.251.35
1.77.49.217.123.4500445.10450.3450.345045045010000000000644644.55645.12645.7
6.900011.27.412.444.840.550.6129.3123266.5273.1293.7310301.83160306227.1219.4224.6207.5258.5304.54312.24252.61
15.920.526.534.253.893124.1172.5154.4186.3197.6196.6227.3230.4273.4292244.7260.8588.7248.3284.7312.9336.2334.9557.8623.63620.08607.04
0.020.030.040.050.090.60.580.220.650.690.780.770.940.50.570.60.550.580.590.550.510.530.560.541.461.571.581.51
0.090.130.260.310.51.111.121.291.421.551.811.751.771.121.591.611.611.651.791.921.881.711.861.752.682.882.832.86
0.10.220.240.431.932.622.652.993.373.84.5755.495.256.136.577.067.715.198.949.369.6410.0910.4311.8412.6913.0813.6
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Amdocs provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Amdocs's financial health and stability.

Assets

Amdocs's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Amdocs must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Amdocs after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Amdocs's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
112453098666-5168234288318364378326343346391412422446409436354479497688549542
25829301552823099710093117165192198195181159140162174211214211205198208224195
24-11-1-4-15-14-11822-21116-191-412-6-26-2625-1430-50-3-60
-11021102642-207611416-13-98-135-153-7297-31-696289139-34-62-82-54-110249-7951
001-218433373467501209311174808286837884967785-115136182
01125622119115244320000001275191619
1118323849777530356240445139461936385951506755754514680156
4332666152287338412391344381429423483519685535514670709772620636557656658925756822
-10-5-10-26-42-56-91-58-62-54-71-80-166-135-83-86-109-122-106-111-120-130-133-231-128-205-210-227-124
-10-5-49-25-41-2-339-65337-260-126-629-441-169-66-211-221-17-297-298-379-440-185-362-86-461-329-262-224
00-390053-247-59599-206-54-548-274-3316-124-111104-190-187-259-310-51-13141-256-118-35-100
00000000000000000000000000000
97-1278-9310457-60-5014-22-700-45019949-5101010-20-20000743-10000
14091330422114-1042-395-7610624-2107-365-567-397-153-243-375-323-253-337-356-263-590-425-440
7-3260-69-5032471-165-48-381-989925-210-442-166-518-449-238-321-460-446-569-425-516315-870-629-651
-16-40-180000000000000000356446-12-1-2-18-11
000-47800000000000000-84-90-100-109-121-134-147-164-177-186-199
2-437-2859317470-406381-297157-10081039307-2044713589-67-267-119-23052511-274-135-53
-5.628.415.939.9110.1231246.1353.7329.4290.3310.4348.5257.5347.2435.9598.3425.7392563.8597.7652.1490.1502.7326.1528.3452.6715.37529.5698.27
00000000000000000000000000000

Amdocs stock margins

The Amdocs margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Amdocs. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Amdocs.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Amdocs's sales revenue. A higher gross margin percentage indicates that the Amdocs retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Amdocs's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Amdocs's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Amdocs's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Amdocs. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Amdocs's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Amdocs Margin History

Amdocs Gross marginAmdocs Profit marginAmdocs EBIT marginAmdocs Profit margin
2026e35.35 %19.03 %15.96 %
2025e35.35 %18.72 %15.46 %
2024e35.35 %17.79 %14.69 %
202335.35 %14.83 %10.88 %
202235.38 %14.53 %11.83 %
202134.46 %13.96 %15.89 %
202033.91 %14.27 %11.85 %
201935.09 %13.96 %11.65 %
201834.71 %12.92 %8.85 %
201735.15 %13.38 %11.2 %
201635.24 %12.99 %10.91 %
201535.52 %14.52 %12.12 %
201435.26 %13.91 %11.84 %
201335.23 %14.39 %12.33 %
201235.77 %13.63 %12.05 %
201134.88 %12.73 %10.91 %
201036.14 %13.75 %11.52 %
200935.91 %13.56 %11.4 %
200835.92 %13.27 %11.98 %
200736.66 %12.84 %12.87 %
200636.14 %14.43 %12.85 %
200536.45 %17.22 %14.16 %
200436.7 %16.7 %13.24 %

Amdocs Stock Sales Revenue, EBIT, Earnings per Share

The Amdocs earnings per share therefore indicates how much revenue Amdocs has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Amdocs earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Amdocs's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Amdocs’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Amdocs's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Amdocs Revenue, EBIT and net profit per share

DateAmdocs Sales per ShareAmdocs EBIT per shareAmdocs Earnings per Share
2026e48.15 undefined0 undefined7.68 undefined
2025e45.98 undefined0 undefined7.11 undefined
2024e44.28 undefined0 undefined6.51 undefined
202341.25 undefined6.12 undefined4.49 undefined
202237.55 undefined5.45 undefined4.44 undefined
202133.51 undefined4.68 undefined5.32 undefined
202031.3 undefined4.47 undefined3.71 undefined
201929.79 undefined4.16 undefined3.47 undefined
201827.87 undefined3.6 undefined2.47 undefined
201726.43 undefined3.54 undefined2.96 undefined
201624.8 undefined3.22 undefined2.71 undefined
201523.48 undefined3.41 undefined2.85 undefined
201422.08 undefined3.07 undefined2.62 undefined
201320.51 undefined2.95 undefined2.53 undefined
201219.17 undefined2.61 undefined2.31 undefined
201117.03 undefined2.17 undefined1.86 undefined
201014.62 undefined2.01 undefined1.68 undefined
200913.74 undefined1.86 undefined1.57 undefined
200814.35 undefined1.9 undefined1.72 undefined
200712.7 undefined1.63 undefined1.63 undefined
200611.35 undefined1.64 undefined1.46 undefined
20059.39 undefined1.62 undefined1.33 undefined
20048.05 undefined1.34 undefined1.07 undefined

Amdocs business model

Amdocs Ltd is a multinational software and service provider, founded in 1982 and headquartered in Chesterfield, Missouri, USA. The company specializes in customer experience solutions for businesses such as telecommunications providers, cable operators, satellite TV broadcasters, and other service providers. Amdocs offers solutions for business process and operations management, customer relationship management (CRM), business intelligence (BI) and analytics, as well as API integration management. The company has established itself as a trusted partner for businesses worldwide. The company's history began in Israel, when a group of engineers had the idea to bypass the strict telecommunications regulations in Israel by developing billing software for telephone services. When their system was successful, the founders recognized the opportunities that lay before them and exported their technology to other countries. In 1985, Amdocs expanded to North America and opened its first office there. The company quickly grew and soon provided solutions to global companies such as AT&T, Vodafone, Singtel, and Orange for their service management needs. In 1998, Amdocs went public on the NASDAQ stock exchange, generating hundreds of millions of dollars in revenue within hours – a testament to the company's success in the industry. Amdocs' business model is based on helping market leaders build profitable customer relationships. The goal is to improve customer interactions, meet expectations better, and streamline processes. These solutions can provide bidirectional contact, enabling customers and service providers to interact in real-time on the same platform. Amdocs' management and service solutions focus on telecommunications services, as well as new customer groups and industries that rely on digital platforms. The company's proprietary problem-oriented approach leads to increased effectiveness and efficiency for customers who choose to work with Amdocs. Amdocs has five main divisions that it covers: 1) Network Services – aiming to provide transport services for telecommunications services. 2) Business Process Management – a comprehensive set of business workflows for customer management, providing solutions for order management, customer service, billing, and invoicing. 3) Customer Management – CRM systems that enable real-time customer engagement and provide information for customer-specific marketing strategies for businesses. 4) Analytics and Big Data Products – BI, predictive analytics, and data warehousing for effective utilization of customer databases and information. 5) Cloud platforms for dialogue and context-related and API integration product management. Amdocs offers a variety of products that function both system-wide and as stand-alone services. Amdocs' key products in the network services division include OSS (Operations Support System) and BSS (Business Support System) software solutions integrated into over 250 service provider systems. Amdocs' business process management solutions enable service providers to have unified management of business processes, while the customer management portfolio offers flexible, scalable CRM solutions. Amdocs' analytics and big data segment supports the consolidation of data from various sources in central data centers to provide insights into complex customer relationships. Amdocs has received several industry awards that confirm the effectiveness of its products and services. Forbes recognized the company as one of the fastest-growing companies in America, and Fortune named it one of the most admired companies in the industry in Asia, Europe, and the USA. The company has also made several acquisitions over the years, predominantly in the USA and Europe. In 2005, Amdocs acquired Qpass, a leading company in the digital products industry, followed by the acquisitions of JacobsRimell in 2008 and Bridgewater Systems in 2012. Overall, Amdocs has established itself as a significant provider of customer experience solutions that are highly valued by many major companies worldwide. With a clear focus on innovation, customer service, and continuous development of tools and systems, Amdocs has revolutionized the telecommunications market and is a key player in the industry. Amdocs is one of the most popular companies on Eulerpool.com.

Amdocs Revenue by Segment

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Amdocs Revenue by Segment

Segmente202320222021
Managed services arrangements2.86 B USD2.76 B USD2.55 B USD
Other2.03 B USD1.82 B USD1.74 B USD

Amdocs Revenue by Region

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Amdocs Revenue by Segment

DateEuropeNorth AmericaNorth America (mainly United States)North America (Mainly United States)Rest of the WorldRest Of World
2023703.14 M USD-3.31 B USD-877.42 M USD-
2022582.19 M USD--3.1 B USD-894.47 M USD
2021622.78 M USD2.79 B USD---874.39 M USD

Amdocs SWOT Analysis

Strengths

1. Established market presence: Amdocs Ltd has built a strong reputation and prominent position in the telecommunications industry.

2. Extensive product portfolio: The company offers a wide range of software and services, including customer experience solutions, cloud-based platforms, and data analytics.

3. Global reach: Amdocs operates in multiple countries, allowing for a diversified revenue stream and access to various markets.

Weaknesses

1. Dependency on key clients: Amdocs relies heavily on a few major clients for a significant portion of its revenue, which poses a risk in case of client loss or downturn in their business.

2. Prone to external market factors: The company's performance can be affected by changes in government regulations, economic conditions, and technological advancements.

3. Limited diversification: Although Amdocs has expanded its product offerings, the majority of its revenue still comes from the telecommunications sector, making it vulnerable to industry-specific challenges.

Opportunities

1. Growing demand for digital transformation: Amdocs can capitalize on the increasing need for companies to adopt digital technologies and enhance their customer experience.

2. Expansion into new industries: The company can explore opportunities in sectors beyond telecommunications, such as financial services and healthcare, to diversify its revenue sources.

3. Potential for strategic partnerships: Collaborating with other technology companies or industry leaders can enable Amdocs to access new markets, expand its offerings, and enhance its competitive advantage.

Threats

1. Intense competition: Amdocs faces fierce competition from other software providers and service vendors in the telecommunications industry, leading to pricing pressures and potential loss of market share.

2. Rapid technological advancements: The need to constantly upgrade and adapt its solutions to keep pace with emerging technologies is a challenge that Amdocs must address to remain competitive.

3. Data security and privacy concerns: As the company deals with sensitive customer data, any breach or mishandling of information can damage its reputation and result in legal implications.

Amdocs Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Amdocs historical P/E ratio, EBIT multiple, and P/S ratio

Amdocs shares outstanding

The number of shares was Amdocs in 2023 — This indicates how many shares 118.489 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Amdocs earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Amdocs's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Amdocs’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Amdocs's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Amdocs dividend history and estimates

In 2023, Amdocs paid a dividend amounting to 1.74 USD. Dividend means that Amdocs distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Amdocs provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Amdocs’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Amdocs's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Amdocs Dividend History

DateAmdocs Dividend
2026e1.92 undefined
2025e1.92 undefined
2024e1.92 undefined
20231.74 undefined
20221.58 undefined
20211.44 undefined
20201.31 undefined
20191.14 undefined
20181 undefined
20170.88 undefined
20160.78 undefined
20150.68 undefined
20140.62 undefined
20130.52 undefined
20120.26 undefined

Amdocs dividend payout ratio

In 2023, Amdocs had a payout ratio of 32.64%. The payout ratio indicates the percentage of the company's profits that Amdocs distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Amdocs represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Amdocs could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Amdocs's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Amdocs Payout Ratio History

DateAmdocs Payout ratio
2026e32.56 %
2025e33.31 %
2024e31.75 %
202332.64 %
202235.55 %
202127.05 %
202035.31 %
201932.85 %
201840.65 %
201729.73 %
201628.78 %
201523.86 %
201423.66 %
201320.55 %
201211.26 %
201132.64 %
201032.64 %
200932.64 %
200832.64 %
200732.64 %
200632.64 %
200532.64 %
200432.64 %
Unfortunately, there are currently no price targets and forecasts available for Amdocs.

Amdocs latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20241.62 1.62  (-0.02 %)2024 Q3
3/31/20241.58 1.56  (-0.99 %)2024 Q2
12/31/20231.58 1.56  (-1.22 %)2024 Q1
9/30/20231.43 1.42  (-0.77 %)2023 Q4
6/30/20231.49 1.57  (5.04 %)2023 Q3
3/31/20231.48 1.47  (-0.94 %)2023 Q2
12/31/20221.33 1.45  (8.71 %)2023 Q1
9/30/20221.3 1.29  (-1.02 %)2022 Q4
6/30/20221.28 1.27  (-0.7 %)2022 Q3
3/31/20221.26 1.54  (22.11 %)2022 Q2
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the Amdocs stock

Eulerpool World ESG Rating (EESG©)

88/ 100

🌱 Environment

99

👫 Social

99

🏛️ Governance

65

Environment

Scope 1 - Direct Emissions
1,327.42
Scope 2 - Indirect emissions from purchased energy
40,093.5
Scope 3 - Indirect emissions within the value chain
41,440.6
Total CO₂ emissions
41,420.9
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
✅
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees32.7
Percentage of women in management—
Percentage of Asian employees24.56
Share of Asian management28.85
Percentage of Hispanic/Latino employees4
Hispano/Latino Management share3.08
Percentage of Black employees3.67
Black Management Share3.08
Percentage of white employees66.79
White Management Share64.36
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Amdocs shareholders

%
Name
Stocks
Change
Date
5.70460 % Janus Henderson Investors6,514,083-222,22812/31/2023
3.71268 % Pzena Investment Management, LLC4,239,513195,62612/31/2023
3.52332 % Beutel, Goodman & Company Ltd.4,023,274-16,86012/31/2023
2.69720 % LSV Asset Management3,079,933-19,54912/31/2023
2.22757 % BlackRock Institutional Trust Company, N.A.2,543,667183,46612/31/2023
2.10082 % Allspring Global Investments, LLC2,398,921-123,2063/31/2024
2.05051 % Parnassus Investments, LLC2,341,473-42,77712/31/2023
13.50402 % Fidelity Management & Research Company LLC15,420,2421,844,01012/31/2023
1.85096 % Invesco Advisers, Inc.2,113,616-34,70012/31/2023
1.83042 % Fidelity Institutional Asset Management2,090,154335,08012/31/2023
1
2
3
4
5
...
10

Most common questions regarding Amdocs

What values and corporate philosophy does Amdocs represent?

Amdocs Ltd represents a set of core values and a strong corporate philosophy. Known for its customer-centric approach, Amdocs focuses on delivering exceptional value and innovation to its clients. The company is committed to providing superior technology solutions and services in the telecommunications industry. Amdocs believes in fostering long-term partnerships, promoting teamwork, and nurturing a culture of integrity and excellence. With its global presence and vast experience, Amdocs continuously strives to redefine and shape the future of communication, ensuring its customers' success in this dynamic business landscape.

In which countries and regions is Amdocs primarily present?

Amdocs Ltd is primarily present in multiple countries and regions across the globe. The company has a strong international presence in countries such as the United States, India, Israel, and the United Kingdom. With extensive operations in over 85 countries, Amdocs provides its innovative software solutions, services, and digital transformation offerings to telecommunications and media companies worldwide. Leveraging its expertise and global footprint, Amdocs has successfully established itself as a trusted partner in the telecom industry, powering advanced customer experience and business support systems for leading service providers around the world.

What significant milestones has the company Amdocs achieved?

Some significant milestones achieved by Amdocs Ltd include its founding in 1982, becoming a publicly traded company on the NASDAQ in 1998, and being listed on the Tel Aviv Stock Exchange in 2002. Amdocs has also achieved global recognition for its innovative software and services in the telecommunications industry. The company has consistently expanded its operations and customer base, establishing a strong presence in over 85 countries. Amdocs has garnered numerous awards and accolades for its technological advancements, customer satisfaction, and commitment to excellence. Continual growth, strategic acquisitions, and partnerships have strengthened Amdocs' position as a leading provider of software and technology solutions.

What is the history and background of the company Amdocs?

Amdocs Ltd is a renowned global software and services provider. Established in 1982, the company has since become a leading player in the telecommunications and media industry. Amdocs specializes in customer experience solutions, business support systems, and digital advertising solutions. With a strong focus on innovation, Amdocs has consistently delivered cutting-edge technologies and services to help Telecom Service Providers enhance their operations and customer experience. Over the years, Amdocs has built a solid reputation for its expertise, reliability, and dedication to customer satisfaction. Today, it continues to thrive as a trusted partner to numerous companies worldwide.

Who are the main competitors of Amdocs in the market?

The main competitors of Amdocs Ltd in the market include companies such as Accenture, CSG Systems International, and Oracle Corporation. These companies offer similar software and services in the telecommunications industry, often competing directly with Amdocs for market share and customer contracts. However, Amdocs Ltd is a leading provider of software and services for communications, media, and entertainment companies globally.

In which industries is Amdocs primarily active?

Amdocs Ltd is primarily active in the telecommunications and media industry.

What is the business model of Amdocs?

Amdocs Ltd is a renowned multinational technology and services company specializing in software and solutions for the telecommunications industry. Their business model revolves around providing comprehensive customer experience solutions, enabling telecom service providers to streamline operations, enhance efficiency, and boost customer satisfaction. Amdocs offers a wide range of products and services, including customer relationship management, revenue management, and digital solutions, tailored to address the unique needs of telecom operators worldwide. With a strong focus on innovation and technology, Amdocs continues to grow as a leader in the telecom industry, delivering cutting-edge solutions and driving digital transformation for their clients.

What is the P/E ratio of Amdocs 2024?

The Amdocs P/E ratio is 14.06.

What is the P/S ratio of Amdocs 2024?

The Amdocs P/S ratio is 2.07.

What is the AlleAktien quality score of Amdocs?

The AlleAktien quality score for Amdocs is 7/10.

What is the revenue of Amdocs 2024?

The expected Amdocs revenue is 5.06 B USD.

How high is the profit of Amdocs 2024?

The expected Amdocs profit is 742.93 M USD.

What is the business model of Amdocs

Amdocs Ltd is a multinational provider of software, services, and solutions for communication service providers and digital network operators. The company was founded in 1982 and is headquartered in Chesterfield, Missouri, USA. Amdocs operates in over 90 countries and employs more than 27,000 employees worldwide. Amdocs is divided into three main divisions: the Customer Business Unit, the Network Business Unit, and the International Business Unit. The Customer Business Unit of Amdocs offers software solutions for telecommunications companies to improve their customer relationships. The solutions cover a wide range of tasks, from managing customer contacts to customer service and billing. This includes CRM (Customer Relationship Management), billing, and order management. The Network Business Unit of Amdocs offers solutions for network operators. This involves network testing, troubleshooting, automation of network management processes, and quality assurance of network performance. The International Business Unit of Amdocs offers comprehensive services for telecommunications companies. These include consulting services, end-to-end process analysis, network planning and design, and implementation of software solutions. Amdocs offers its customers a wide range of products and solutions. One of the most well-known products is Amdocs CES (Customer Experience Solution), an industry solution that includes various modules such as CRM, billing, and order management. Amdocs also offers a comprehensive portfolio of cloud solutions that provide customers with a flexible and scalable IT infrastructure. In addition to its industry solutions, Amdocs also offers solutions for implementing digital business processes and meeting customer requirements. These include digital billing solutions and analytics tools for measuring customer experiences and the effectiveness of marketing campaigns. Amdocs' business model is based on the continuous expansion of its innovative services and solutions, as well as its global presence. The company conducts research and development in key areas such as artificial intelligence, cloud technology, and big data to offer innovative solutions to its customers. Amdocs has a strong customer base in the telecommunications sector, including major companies such as AT&T, Vodafone, and Telefonica. Through further development of industry-leading solutions and services, the company is well positioned to strengthen its market position and expand its customer base. In summary, Amdocs is a leading provider of software solutions and services for telecommunications companies. The company is divided into three main divisions and offers its customers a wide range of products and services. Amdocs continuously conducts research and development in key areas to offer innovative solutions to its customers and strengthen its market position.

What is the Amdocs dividend?

Amdocs pays a dividend of 1.58 USD distributed over 4 payouts per year.

How often does Amdocs pay dividends?

Amdocs pays out a dividend 4 times a year.

What is the Amdocs ISIN?

The ISIN of Amdocs is GB0022569080.

What is the Amdocs WKN?

The WKN of Amdocs is 915119.

What is the Amdocs ticker?

The ticker of Amdocs is DOX.

How much dividend does Amdocs pay?

Over the past 12 months, Amdocs paid a dividend of 1.74 USD . This corresponds to a dividend yield of about 1.97 %. For the coming 12 months, Amdocs is expected to pay a dividend of 1.92 USD.

What is the dividend yield of Amdocs?

The current dividend yield of Amdocs is 1.97 %.

When does Amdocs pay dividends?

Amdocs pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Amdocs?

Amdocs paid dividends every year for the past 15 years.

What is the dividend of Amdocs?

For the upcoming 12 months, dividends amounting to 1.92 USD are expected. This corresponds to a dividend yield of 2.18 %.

In which sector is Amdocs located?

Amdocs is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von Amdocs kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amdocs from 10/25/2024 amounting to 0.479 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.

When did Amdocs pay the last dividend?

The last dividend was paid out on 10/25/2024.

What was the dividend of Amdocs in the year 2023?

In the year 2023, Amdocs distributed 1.58 USD as dividends.

In which currency does Amdocs pay out the dividend?

The dividends of Amdocs are distributed in USD.

All fundamentals about Amdocs

Our stock analysis for Amdocs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amdocs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.